AEterna Zentaris Incorporated (AEZ) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

AEterna Zentaris Incorporated Company Snapshot

Business Description:

AEterna Zentaris Incorporated operates in the Pharmaceutical preparations sector. Aeterna Zentaris Inc. (Aeterna Zentaris) is a drug development company specialized in oncology and endocrine therapy. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. The priorities in oncology are its Phase III program with perifosine in multiple myeloma and colorectal cancer, combined with its Phase I program in multiple cancers, as well as the further advancement of AEZS-108. The Company completed with a Phase II trial in advanced endometrial and advanced ovarian cancer. In endocrinology, the Company's lead program is its Phase III trial with AEZS-130 (Solorel) as a growth hormone (GH) stimulation test for the diagnosis of GH deficiency in adults. The Company has three wholly owned direct and indirect subsidiaries, which include Aeterna Zentaris GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc. In our complete report available for purchase the company is compared to: Afexa Life Sciences Incorporated, Cardiome Pharma Corp. and QLT Inc..

AEterna Zentaris Incorporated

Stock Performance Chart for AEterna Zentaris Incorporated

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 1.64
(Figures in Canadian Dollars)

1 Week	-10.9%		13 Weeks	-4.1%

4 Weeks	2.5%		52 Weeks	-6.3%

AEterna Zentaris Incorporated Key Data:

	Ticker:	AEZ	Country:	CANADA

	Exchanges:	NAS MON TOR	Major Industry:	Drugs, Cosmetics & Health Care

			Sub Industry:	Ethical Drug Manufacturers

	2010 Sales	28,687,288 (Year Ending Jan 2011).	Employees:	489

	Currency:	Canadian Dollars	Market Cap:	169,894,116

	Fiscal Yr Ends:	December	Shares Outstanding:	103,593,973

	Share Type:	Sub.Voting	Closely Held Shares:	811,091

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.